Condition
Extranodal Marginal Zone Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Extranodal Marginal Zone Lymphoma clinical trials that are recruiting, in United States. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Nemtabrutinib plus rituximab for marginal zone lymphoma
This phase 2 trial tests whether combining nemtabrutinib with rituximab can help people with marginal zone lymphoma.
-
Testing Mosunetuzumab for Newly Diagnosed Extranodal Marginal Zone Lymphoma
This study is testing a new medication called Mosunetuzumab to see if it can help people with newly diagnosed Extranodal Marginal Zone Lymphoma feel better compared to standard treatments.
Related topics
Quick answers
How many Extranodal Marginal Zone Lymphoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.